Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

oils4cure Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis Complex

Coordinator
Oils4cure SL, Spain
Runs
1 December 2023 to 31 August 2026
Status
Running
EU funding
€1.6m
Total cost
€2.2m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190119321

What the project is doing

In the project's own words, from its summary on CORDIS.

OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on full spectrum medicinal cannabis extracts. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis complex (YCJ-01) and another for Leukodystrophies (YCJ-02), both paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis complex (TSC).

Topics

Who is involved

OrganisationCityCountryRole
Oils4cure SLMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI